Reassessing the risk of natalizumab-associated PML
Crossref DOI link: https://doi.org/10.1007/s13365-016-0427-6
Published Online: 2016-02-03
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Berger, Joseph R.
Fox, Robert J.
Funding for this research was provided by:
None
Text and Data Mining valid from 2016-02-03